To identify molecular mechanisms that may mediate resistance to mitochondrial Kv1.3 inhibitors PAPTP and PCARBT in multiple myeloma and to counteract them, we aimed to generate PCARBTP- and PAPTP-resistant cell lines. The gene discussed is KCNA3; the disease is AL amyloidosis.